Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

AzurRx BioPharma (AZRX) Competitors

AzurRx BioPharma logo
No competitors for AzurRx BioPharma were found.

Get AzurRx BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZRX and its competitors with MarketBeat's FREE daily newsletter.

AZRX vs. The Competition

MetricAzurRx BioPharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$3.87M$6.51B$5.09B$8.84B
Dividend YieldN/A8.11%5.04%4.07%
P/E Ratio-0.046.16101.4814.96
Price / SalesN/A366.491,207.9887.23
Price / CashN/A52.5939.7136.27
Price / Book-0.5510.176.936.35
Net Income-$32.67M$153.13M$118.81M$225.93M

Related Companies and Tools


This page (NASDAQ:AZRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners